Apr 22, 2021
Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfront Vertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against bluebird bio to the market with a novel gene-editing therapy for sickle cell disease and beta-thalassemia called CTX001. B...
Read More...
Apr 21, 2021
Over the past few decades, the estimated incidence and prevalence of digestive disorders have increased significantly. Some of the factors such as industrialization, changing dietary habits, use of antibiotics, smoking, infection, sanitation, and many others have contributed to this inclining trend. Digestive Di...
Read More...
Apr 20, 2021
Adagio Raises $336 Million to Advance Covid-19 Antibody Treatment An antibody startup Adagio Therapeutics announced the completion of a $336 million Series C financing round. The proceedings from the financing round will be used to augment the development of the company’s lead program developing treatments for C...
Read More...
Feb 12, 2025
Alzheimer's disease continues to pose a significant challenge to global healthcare systems, with the 7MM reporting approximately 16 million diagnosed prevalent cases in 2023. This rising AD prevalence highlights an urgent need for innovative treatments to mitigate the growing disease burden on both patients and car...
Read More...
Apr 16, 2021
Bone tumors are uncommon in adults, however, are a frequent cause of neoplastic diseases among children and the younger population. Primary malignant bone tumors account for approximately 6% of all childhood malignancies with Ewing’s sarcomas as the second most frequently occurring primary malignant bone tumors in ...
Read More...
Apr 15, 2021
Lilly’s RET inhibitor Retevmo exhibits early promise in new cancer types The phase 1/2 LIBRETTO-001 trial enrolled 32 patients with 12 unique RET fusion-positive advanced cancer types, comprising pancreatic, colon, breast and salivary cancer, with 62.5% affected by gastrointestinal tumours. Across all 32 pati...
Read More...
Apr 14, 2021
Sleep is essential for the physical and mental health of the person. If a person didn’t get proper sleep, it might lead to many health complications. In recent time, due to various reasons such as busy work schedule, changes in sleep patterns, stress, environmental factors, certain medical conditions or medications...
Read More...
Apr 13, 2021
Taysha takes charge of a Rare Disease Gene Therapy for $5.5 M Taysha Gene Therapies announced the acquisition of exclusive global rights to TSHA-120 from a leading patient advocacy group for an upfront payment of USD 5.5 million. TSHA-120 is an intrathecally dosed AAV9 gene therapy designed to tre...
Read More...
Apr 12, 2021
Alpha1-antitrypsin deficiency (AATD) was first identified by Carl-Bertil Laurell and Sten Eriksson (Laurell and Eriksson 1963) in 1963, who discovered a link between low plasma serum AAT levels and pulmonary emphysema symptoms. With time as the understanding of the genetic abnormalities grew, AAT deficiency c...
Read More...
Apr 09, 2021
Eating food is the most regular habit a person divulges into without realizing its importance. Consumption of food, although linked with gaining necessary nutrients, vitamins and minerals, holds much more weight than that. Either to celebrate or to cheer up someone going through bad situations, treating them with f...
Read More...